Many comatose post cardiac arrest (CA) patients die or survive with severe disability after a prolonged ICU stay associated with important cost burden. Conversely, the potential for premature withdrawal of life support from patients who may have a chance of functional recovery represents an additional ethical dilemma. Thus, finding accurate prognostic indicators that can reliably identify patients who have a likelihood of meaningful neurologic recovery is a very important healthcare issue ([@R1]). Lately, important advances have been made in clinical evaluation, electrophysiology and neuroimaging, providing insights into the underlying pathophysiologic mechanisms of brain injury induced by CA, as well as prognosis ([@R2]). Nevertheless, it is worth noting that studies in this field ([@R2], [@R3]) have been prone to substantial biases as: 1) self-fulfilling prophecies of early withdrawal of life-sustaining therapies (i.e., treating physicians were not blinded to the results of prognostic test), 2) small sample size and heterogeneity of patients populations, and 3)poorly described outcome measures, generally focused on short-term prognostication.

Regarding the brain structural impact of CA, it has been suggested by histological and animal studies that anoxic/hypoxic encephalopathy is related to diffuse and severe structural damages encompassing brain swelling, cortical laminar necrosis, and basal ganglia necrosis ([@R4]). Gray matter seems to have far greater vulnerability to hypoxia when compared with white matter, particularly in brain regions showing high basal metabolic levels ([@R5]). Nevertheless, brain gray matter architectural changes induced by CA have not yet been systematically explored in CA survivors, probably because conventional MRI sequences, as T1-weighted sequences, are currently considered not precise enough to detect brain structural anomalies in this setting and are supposed to fail to accurately predict outcome when they are used alone in patients with anoxic/hypoxic encephalopathy ([@R2]). However, neuroimaging analysis techniques have greatly advanced over the years, and innovative neuroimaging methods hold the promise for providing in vivo insight into these pathophysiologic processes. For example, cortical thickness measurement and deep gray matter quantitative volumetry have been recently used to allow a fine-grained assessment of brain volumes atrophy related to neurodegenerative disorders ([@R6], [@R7]).

We hypothesize that the use of cortical thickness measurement and subcortical gray matter quantitative volumetry could provide an accurate in vivo assessment of the impact of anoxic/hypoxic insult induced by CA. We speculate that cortical and subcortical volume atrophy measurements provided by these approaches could be used as accurate predictors of long-term neurologic outcome in this setting. To test this hypothesis, we prospectively studied a large and multicenter cohort of anoxic comatose patients. All patients were prospectively recruited and managed according to standard of care recommendations ([@R5]) by clinical practitioners blinded to MRI data, to avoid bias related to self-fulfilling prophecies. Patients were scanned during the acute phase following the CA, exclusively during coma state, in standardized clinical conditions. Finally, the prognostic value of neuroimaging recordings was assessed against long-term neurologic outcome using a validated clinical score ([@R8]), 1 year after injury.

MATERIALS AND METHODS
=====================

Participants
------------

This prospective, multicenter study was undertaken in five Intensive Critical Care Units affiliated to the University in Toulouse (France), Paris (France), Clermont-Ferrand (France), Liège (Belgium), and Monza (Italy) between October 2011 and October 2014. We compared CA survivors who met the strict clinical definition of coma (Glasgow Coma Scale at the admission to hospital \< 8 with motor responses \< 6) to sex and age-matched healthy volunteers. In patients, clinical examination was repeatedly performed using standardized scales (Glasgow Coma Score on the day of scanning and 1 year later using the Glasgow Outcome Scale \[GOS\]-E \[[@R8]\]). All patients were prospectively recruited and managed according to standard of care recommendations ([@R5]) by clinical practitioners blinded to MRI data. The Ethics committee of each recruiting center approved this study. Informed consent to participate to the study was obtained from the subjects themselves in the case of healthy subjects and from the legal surrogate of the patients.

Imaging Procedures
------------------

### Acquisitions.

In all subjects, high-resolution anatomical image, using 3D T1-weighted sequence (in plane, 160 contiguous slices) was acquired using 3 T MR scanners. All patients were scanned less than 1 month after CA (MRI delay after CA, 16 ± 8 d). Monitoring of vital variables was performed by a senior intensivist throughout the experiment. All patients were in coma during the MRI scan.

### Analysis.

Analysis was performed by investigators who were blinded to the clinical information and outcomes data. To proceed to cortical thickness measurement, brain volumes were resampled to a 1 × 1 × 1 mm resolution and then segmented using Statistical Parametric Mapping 8 (<http://www.fil.ion.ucl.ac.uk/spm/>). Cortical thickness was computed on the whole cortical ribbon in the native space of the subject's brain, using a Laplace's equation-based algorithm ([@R9]). The 3D cortical thickness map was registered in a standardized and parcellated into 96 areas (48 Brodmann areas × 2 hemispheres). To reinforce the robustness of the measures, these areas were then grouped into 20 zones (10 zones × 2 hemispheres) following pathophysiologic criteria ([@R7]). A mean cortical thickness was computed for each zone of each subject (mean between right and left brain hemispheres).

Deep gray matter quantitative volumetry was performed using FSL 4.1 (FMRIB, Software Library V5.0, Analysis Group, Oxford, United Kingdom; <http://www.fmrib.ox.ac.uk/fsl/>) and in house software developed in Matlab ([@R6]). For each subject, deep gray matter structures and brain stem were segmented. To reduce the effects of interindividual variability in head size, individual volume values were multiplied by a normalization factor from the corresponding T1-weighted image.

Outcome Assessment
------------------

All patients were followed up until death or 1 year after CA in survivors. The principal outcome measure was the extended version of the GOS-E ([@R8]), which was measured by blinded assessors. This scale classifies patients into eight categories as follows: GOS-E score of 1, death; 2, vegetative state/unresponsive wakefulness syndrome; 3, lower severe disability; 4, upper severe disability; 5, lower moderate disability; 6, upper moderate disability; 7, lower good recovery; and 8, upper good recovery. Among survivors, any GOS-E score from 2 to 4 was defined as an "unfavorable outcome" (UFO), whereas a score from 5 to 8 was defined as a "favorable outcome" (FO).

Statistical Analysis
--------------------

Normally distributed variables were expressed as mean ± [sd]{.smallcaps} and nonnormally distributed variables as median (interquartile range, 25--75). FO patients were compared with UFO patients. Continuous variables were compared using Student *t* test or the Mann-Whitney *U* test, as appropriate. A Student-Newman-Keuls post hoc analysis was used to identify sample means that are significantly different from each other. Categorical variables were compared using the chi-square test.

To examine the potential relationship between cortical and subcortical morphometric changes induced by hypoxic/anoxic insult, a cross-correlation matrix and a principal component analysis (PCA) were applied to the whole dataset.

To specifically address the prognosis value of cortical thickness measurement and subcortical gray matter quantitative volumetry, we used a supervised learning machine approach to elaborate and validate a mathematical model trained on labeled examples. To do so, two independent patients sample were used: 1) a learning sample was employed to establish the best classification model and then was tested using a repeated 10-fold cross-validation procedure and 2) a validation sample, which was not used during the previous phase and was employed to test degeneralization of the model.

Normalized cortical and subcortical morphometric data were used as independent variables and employed to estimate partial least square (PLS) regression ([@R10]) (**e-text1**, Supplemental Digital Content 1, <http://links.lww.com/CCM/C459>) to predict two final diagnoses (FO and UFO) using a unique linear multivariate model. Nonsurvivors patients (GOS-E score of 1) were not included in this predictive analysis. Actually, patient's mortality during the early phase after CA resuscitation is frequently related to multiple organ failures, which could not be directly related to CA-induced structural brain injury and consequently to patient's potential of neurologic recovery. Furthermore, decisions of early withdrawal of life-sustaining therapies constitute a potential confounder in this setting and justify taking into account this possible source of bias ([@R2]).

PLS latent variables were calculated from the largest covariance between the independent and dependent variables (MRI data and outcome, respectively). PLS components with an eigenvalue superior to one were included in the model. To avoid overfitting risk, the data of the validation set were used to evaluate the predictive abilities of the obtained model. The standardized coefficients and 95% CIs of each variable were determined using a bootstrap procedure (100,000 permutations). Finally, a binary logistic regression was performed on the PLS components to convert PLS values of each observation into a probability score.

Receiver operating characteristic (ROC) ([@R11]) curves were calculated for the predictive model, and the highest sum of sensitivity and specificity was considered as being the optimal threshold. Positive and negative likelihood ratios were also estimated from this optimal threshold. All *p* values were two-tailed, and statistical significance was defined as a *p* value of less than 0.05. Analyses were performed using SPSS (SPSS, Chicago, IL), Statistica (Statsoft, Tulsa, OK), and Tanagra 1.4.50 (Rakotomalala, Lyon University, France) softwares.

RESULTS
=======

Participants
------------

We compared 126 CA survivors who met the clinical definition of coma (sex ratio, 0.8; age range, 23--51) to 70 sex and age-matched healthy volunteers (sex ratio, 0.7; age range; 24--45). **e-table 1** (Supplemental Digital Content 2, <http://links.lww.com/CCM/C460>) and **e-fig. 6** (Supplemental Digital Content 9, <http://links.lww.com/CCM/C467>---legend, Supplemental Digital Content 10, <http://links.lww.com/CCM/C46>) report demographic and clinical characteristics of the patients. To predict outcome in 1-year survivors (37 from the initial 126 patients), data from these patients were used to constitute a learning sample aiming to elaborate a predictive model using machine-learning techniques. Additionally, a validation sample of CA patients in coma, exclusively recruited in Toulouse (18 CA patients in coma, sex ratio, 0.9; age range, 22--57) and which was not used during the previous phase, was used to test the model generalization.

CA Impact on Brain Volumes
--------------------------

Whole brain mean cortical thickness significantly differed between patients and controls (**Fig. [1](#F1){ref-type="fig"}**). Furthermore, a Newman-Keuls post hoc analysis showed that all cortical zones significantly differed in terms of cortical thickness between both groups (interaction group × anatomical region, *F* = 10.9; *p* \< 0.0001).

![Quantitative cortical (**A**) and subcortical (**B** and **C**) morphometric differences between patients and controls. Normalized 3D cortical thickness maps (mm) and subcortical volumes (mm^3^) were obtained and compared between coma patients and sex and age-matched controls (false discovery rate corrected *p* values for multiple comparisons, *p* \< 0.05). Accub = accumbens nucleus, Amyg = amygdala, Audit = auditory cortex, Caud = caudate nucleus, CingAnt = anterior cingulate cortex, CingPost = posterior congulate cortex, Frontal = frontal cortex, Hipp = hippocampus, Insula = insula, Occip = occipital cortex, Pariet = parietal cortex, Pall = pallidum, Puta = putamen, SenMot = sensory motor cortex, TempLat = lateral temporal cortex, TempMed = medial temporal cortex, Thal = thalamus.](ccm-45-e763-g001){#F1}

Regarding subcortical morphometric changes induced by CA, results showed that the global measurement of basal ganglia, thalamus, and brain stem volumes was significantly different between coma patients and controls (Fig. [1](#F1){ref-type="fig"}). In sum, anoxic comatose patients displayed significantly extensive cortical and subcortical brain volumes atrophy compared with sex- and age-matched controls.

Cortical and Subcortical Specific Vulnerability
-----------------------------------------------

To examine the potential relationship between cortical and subcortical morphometric changes induced by hypoxic/anoxic insult, a cross-correlation matrix (**Fig. [2](#F2){ref-type="fig"}*A***) and a PCA were applied to the whole dataset (Fig. [2](#F2){ref-type="fig"}***B***). It is worth noting that the whole brain morphometric correlation matrix suggests a dissociated cortical and subcortical pattern of structural susceptibility (Fig. [2](#F2){ref-type="fig"}*A*). Congruently, the distribution of the PCA values (Fig. [2](#F2){ref-type="fig"}*B*) with the two first components uncovers the fact that the cortical atrophy observed in all the defined brain zones significantly correlates to principal component 1 and that the volume decrease, which has been identified in subcortical structures (i.e., basal ganglia, thalamus, and brain stem) in patients compared with controls, seems to be independent of the degree of cortical atrophy, as suggested by their significant correlation with the principal component 2.

![**A**, Whole brain morphometric correlation matrix. Table showing the Pearson correlation (*r*) coefficients between cortical and subcortical gray matter morphometric data. Direction and strength of the linear relationship between the variables (whether causal or not) is represented by *r* values (ranging from --1 to +1, coded in blue to red, respectively). A correlation matrix is symmetric because the correlation between *X*~*i*~ and *X*~*j*~ is the same as the correlation between *X*~*j*~ and *X*~*i*~. It is worth noting that volumetric changes in subcortical regions are mainly correlated with anatomical changes in others subcortical structures (i.e., left and upper part of the matrix). As a counterpart, the degree of cortical atrophy induced by CA seems to be specifically correlated with the volumetric changes observed in other cortical regions (i.e., right and lower part of the matrix). **B**, Principal component analysis (PCA) of cortical thickness and subcortical volumes measured in patients (82% of the variability is accounted on the component 1/component 2 plane). PCA is a statistical procedure that uses an orthogonal transformation to convert a set of observations of possibly correlated variables into a set of values of linearly uncorrelated variables called "principal components." PCA is mostly used as a tool in exploratory data analysis and can be thought of as revealing the internal structure of the data in a way that best explains the variance in the data. In this case, PCA method permits to identify that the morphometric changes induced by CA are significantly correlated among cortical regions (i.e., correlation with component 1) and within the set of subcortical volumes (i.e., correlation with component 2) but are largely independent between them (i.e., orthogonal components). Accub = accumbens nucleus, Amyg = amygdala, Audit = auditory cortex, BS = brain stem, Caud = caudate nucleus, CingAnt = anterior cingulate cortex, CingPost = posterior congulate cortex, Frontal = frontal cortex, Hipp = hippocampus, Insula = insula, Occip = occipital cortex, Pall = pallidum, Pariet = parietal cortex, Puta = putamen, SenMot = sensory motor cortex, TempLat = lateral temporal cortex, TempMed = medial temporal cortex, Thal = thalamus.](ccm-45-e763-g002){#F2}

To summarize, the impact of CA on subcortical and cortical gray matter morphometry seemed to be dissociated. A specific pattern of atrophy was observed among cortical regions and between the whole set of subcortical structures. In other words, regarding CA-induced gray matter volume reductions, cortical and subcortical structures behave as independent groups: the volumetric change of each gray matter structures seems to be specifically correlated with the degree of atrophy that is observed in structures of the same group (i.e., cortical vs subcortical).

Predictive Value
----------------

Admission characteristics of the patients according to their outcome are presented in e-table 1 (Supplemental Digital Content 2, <http://links.lww.com/CCM/C460>); there were no significant demographic differences between survivors' comatose patients with favorable (GOS-E, 5--8) and UFO (GOS-E, 2--4). No difference was found in the timing of MRI scan between FO and UFO patients. Nevertheless, patients with FO differed from patients with UFO by a significant and specific decrease of cortical thickness in the frontal cortex (*p* \< 0.001) and the volume reduction at the level of the thalamus, putamen, and pallidum (*p* \< 0.001, *p* \< 0.01, and *p* \< 0.008, respectively) (**Table [1](#T1){ref-type="table"}**).

###### 

Patients Outcome and Brain Quantitative Morphometry

![](ccm-45-e763-g003)

Additionally, we investigated using machine-learning methods the accuracy of a predictive classifier built on the whole dataset of cortical thickness and subcortical volumes measurements. One model was tested using morphometric data (**e-fig. 1**, Supplemental Digital Content 4, <http://links.lww.com/CCM/C462>---legend, Supplemental Digital Content 10, <http://links.lww.com/CCM/C468>; and **e-fig. 2**, Supplemental Digital Content 5, <http://links.lww.com/CCM/C463>---legend, Supplemental Digital Content 10, <http://links.lww.com/CCM/C468>). During the learning phase, area under the ROC (area under the curve \[AUC\]) values showed that a composite model encompassing cortical and subcortical components has the optimal discriminative power (AUC = 0.87; **Fig. [3](#F3){ref-type="fig"}**) (**e-table 2**, Supplemental Digital Content 3, <http://links.lww.com/CCM/C461>). Data obtained during the validation phase confirm the accuracy and robustness of the predictive model (AUC = 0.96; Fig. [3](#F3){ref-type="fig"}) (e-table 2, Supplemental Digital Content 3, <http://links.lww.com/CCM/C461>; **e-fig. 3**, Supplemental Digital Content 6, <http://links.lww.com/CCM/C464>---legend, Supplemental Digital Content 10, <http://links.lww.com/CCM/C468>; and **e-fig. 5**, Supplemental Digital Content 8, <http://links.lww.com/CCM/C466>---legend, Supplemental Digital Content 10, <http://links.lww.com/CCM/C468>). It must be highlighted that the anatomical regions which volume changes were significantly related to patient's outcome in the combined predictive model were frontal cortex, posterior cingulate cortex, thalamus, putamen, pallidum, caudate and brain stem (**Fig. [4](#F4){ref-type="fig"}**). Finally, to illustrate the potential bedside use of this approach for neuroprognostication, the cross-validated predictive model described in the current study was integrated in an open-source application which permits the individual estimation of 1-year outcome of CA survivors patients in coma, using MRI gray matter morphometric data (**e-fig. 4**, Supplemental Digital Content 7, <http://links.lww.com/CCM/C465>---legend, Supplemental Digital Content 10, <http://links.lww.com/CCM/C468>).

![Predictive value. Receiver operating characteristic curves depicting the relationship between the proportion of true-positive findings and the proportion of false-positive findings. Estimation performances on outcome prediction of the combined morphometric cortical and subcortical partial last square model (favorable outcome vs unfavorable outcome) are represented as areas under the curve (AUC). Learning sample AUC = 0.87 (0.67--0.95); test sample AUC test = 0.96 (0.88--1).](ccm-45-e763-g004){#F3}

![Model components. Cortical and subcortical morphometric data were used as independent variables and then employed to estimate partial last square (PLS) regression to predict final outcome. PLS components with an eigenvalue superior to 1 were included in the multivariate predictive model (favorable outcome vs unfavorable outcome). Normalized PLS coefficients, obtained by a bootstrap procedure (100,000 permutations), are depicted as whisker box plots (median, interquartile range, 95% CI). The *bottom* illustrates the topography of the cortical (*red*) and subcortical (*blue*) structures, whose structural changes were significantly associated with 1-year patients outcome. Accub = accumbens nucleus, Amyg = amygdala, Audit = auditory cortex, Caud = caudate nucleus, CingAnt = anterior cingulate cortex, CingPost = posterior congulate cortex, Frontal = frontal cortex, Hipp = hippocampus, Insula = insula, Pall = pallidum, Puta = putamen, Occip = occipital cortex, Pariet = parietal cortex, SenMot = sensory motor cortex, TempLat = lateral temporal cortex, TempMed = medial temporal cortex, Thal = thalamus.](ccm-45-e763-g005){#F4}

DISCUSSION
==========

Neuroimaging shows promise for determining early prognosis based on structural brain injury ([@R2]). Nevertheless, conventional MRI sequences, as T1-weighted sequences, are presently considered not precise enough to detect brain structural anomalies induced by CA ([@R2]). The current study suggests that the use of gray matter morphometry, obtained from standard brain T1-weighted acquisition, enables an accurate in vivo evaluation of the structural impact of anoxic/ischemic brain injury in this challenging setting.

Remarkably, our data suggest that the prognostic value of gray matter morphometry in CA survivors is not related to the total amount of cortical or subcortical global atrophy induced by CA, but to the specific structural impairment of the frontal cortex, the posterior cingulate cortex, the hippocampus, the brain stem, the thalamus, and the striatopallidal system. All these cortical and subcortical structures are believed to underlie conscious processing ([@R12]) and willful behavior ([@R13]). Indeed, both the frontal cortex and the posterior cingulate cortex have dense structural and functional connections suggesting a role as cortical hubs ([@R14]), an essential property for complex cognitive process ([@R15]). A selective hypometabolism in these cortical structures has been reported in a wide range of altered conscious states such as sleep ([@R16]), drug-induced anesthesia ([@R17]), or acquired disorders of consciousness induced by brain injury ([@R18], [@R19]). The brain stem, encompassing the ascending reticular activation system, is located at a critical juncture in the inflow of sensory information and can modulate wakefulness and awareness. It is worth noting that a significant impairment of functional connectivity has been described in anoxic/ischaemic patient with chronic disorders of consciousness, between the brain stem and the posterior cingulate cortex/précuneus ([@R20]) or the hippocampus ([@R21]). Finally, thalamic and striatopallidal structures are interconnected in large-scale loops that are involved in forebrain function ([@R22]). Corticothalamic and corticostriatal dynamic connectivity seems to be crucial for high-level cognitive processing including attentional focus ([@R23]), volition ([@R24]), and motor control ([@R25]). The integrity of these cortico-subcortical networks has been related to the severity of a patient's disorder of consciousness on acute ([@R26]) and chronic setting ([@R27]). Overall, these findings are consistent with the idea that functional/structural impairment within a cortico- striatopallidal-thalamo-cortical mesocircuit is characteristic of disorder of consciousness observed in severe brain injury patients ([@R28]).

Additionally, our data suggest that gray matter quantitative morphometry could be useful to improve our understanding of the underlying pathophysiology of hypoxic/anoxic encephalopathy. Actually, we identified early after CA, a specific pattern of atrophy of gray matter volumes, suggesting a dissociated vulnerability to primary hypoxic/anoxic injury ([@R29]) or secondary brain insults ([@R5]), of cortical regions compared with subcortical structures. Alternatively, this dissociated pattern of anatomical coupling between cortical/subcortical structures after CA could be interpreted as the consequence of massive anatomical ([@R30]) and functional ([@R18]) long-range disconnections between these structures, in agreement with theoretical models conscious processing ([@R13], [@R31]).

Studies in the challenging field of neuroprognostication of hypoxic-ischaemic coma are prone to substantial biases ([@R2], [@R32]). The present multicenter prospective study was designed to limit the impact of inherent biases as the sample size, the heterogeneity of the studied population, the timing of patient's assessment, and circular reasoning (i.e., self-fulfilling prophecy) ([@R33]). Nevertheless, our study has several limitations. As a variant with previous neuroimaging studies of disorders of consciousness ([@R34]), we controlled potential confounding factors, by a sex and age match between patients and healthy volunteers. Nevertheless, it could be argued that additional factors, such as comorbid conditions ([@R7]) or sociocultural level ([@R35]), could potentially contribute to brain atrophy. This point needs to be addressed in future studies in the field. Furthermore, the current study was designed to provide a snapshot of the impact of CA on brain gray matter volumes, and the timing of neuroimaging acquisitions was decided to obtain the best balance between clinical relevance and study feasibility. Several points must be highlighted that justify the level standardization and consistency in the timing of MRI of the current study: 1) to avoid confounding factors, all patient MRI assessments were conducted at least 2 days (4 ± 2 d) after a complete withdrawal of sedative drugs therapies and under normothermic conditions, 2) to guarantee patients management according to standard of care recommendations, patients transfer to the imaging centers was exclusively performed after achievement of clinical stability, and 3) to specifically address the impact of cortical and subcortical gray matter atrophy induced by CA, we focused the MRI assessment during the consistent acute period that follows early brain edema development. Future longitudinal neuroimaging studies will need to focus on repeated brain scan acquisitions after CA, aiming to disentangle the dynamic structural signatures of brain injury in this setting and ultimately identify the best timing to use such neuroimaging biomarkers for neuroprognostication.

We do not anticipate that the brain cortical and subcortical quantitative morphometry will be used in isolation as a prognosticator for post CA patients, but rather in conjunction with other prognostic variables ([@R2], [@R36]). Clinicians should continue to use all the available tools to provide accurate prognostic advice in this challenging setting. Eventually, we suggest that a quantitative prognostic outcome model incorporating serial neurologic assessment, multimodal MRI (encompassing structural and functional data) with variables such as electrophysiologic measurement, is likely to prove most powerful in assisting in decision making regarding continuation or withdrawal of life support in these patients.
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